• LAST PRICE
    0.6100
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-6.1538%)
  • Bid / Lots
    0.6000/ 40
  • Ask / Lots
    0.6100/ 32
  • Open / Previous Close
    0.6149 / 0.6500
  • Day Range
    Low 0.6100
    High 0.6149
  • 52 Week Range
    Low 0.3300
    High 2.8999
  • Volume
    4,225
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.65
TimeVolumePETV
03:34 ET42090.61
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPETV
PetVivo Holdings Inc
11.1M
-0.7x
---
United StatesCTGL
Citrine Global Corp
9.7M
-4.0x
---
United StatesSINT
SINTX Technologies Inc
9.8M
0.0x
---
United StatesBMRA
Biomerica Inc
10.8M
-1.7x
---
United StatesARTH
Arch Therapeutics Inc
6.6M
-0.3x
---
United StatesPOAI
Predictive Oncology Inc
6.6M
-0.4x
---
As of 2024-05-24

Company Information

PetVivo Holdings, Inc. is a biomedical device company. The Company is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The Company has a pipeline of therapeutic devices for both veterinary and human clinical applications.

Contact Information

Headquarters
5251 Edina Industrial BlvdEDINA, MN, United States 55439
Phone
952-217-4952
Fax
775-884-9383

Executives

Non-Executive Independent Chairman of the Board
Gregory Cash
President, Chief Executive Officer, Director
John Lai
Chief Financial Officer
Garry Lowenthal
Chief Operating Officer, Director
Randall Meyer
Vice President - Business Development, General Counsel, Company Secretary, Director
John Dolan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$11.1M
Revenue (TTM)
$1.0M
Shares Outstanding
17.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.24
EPS
$-0.87
Book Value
$0.07
P/E Ratio
-0.7x
Price/Sales (TTM)
10.6
Price/Cash Flow (TTM)
---
Operating Margin
-1,016.12%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.